Hadfield, Matthew J.

The evolving landscape of antibody-drug conjugates (ADCs) for treatment of prostate cancer

Lin, C., Hadfield, M. J., Santopietro, A., Lagos, G., Cheng, L., El-Deiry, W. S., Aggarwal, R., Mega, A., Hyams, E., & Carneiro, B. A. (2025) · npj Precision Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 20

Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists

Hadfield, M. J., Lyall, V., Holle, L. M., & Dennison, M. (2023) · Annals of Pharmacotherapy

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 10